Profund Advisors LLC Novo Cure LTD Transaction History

Profund Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $126,392 - $211,670	-1,088 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $141,875 - $245,431	1,088 New	1,088 $241,000
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $150,326 - $252,301	-2,635 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$68.3 - $93.8 $179,970 - $247,163	2,635 New	2,635 $222,000

290

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.2B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.